Possibilities and real meaning of assessment of ovarian reserve

Czech version

Authors: M. Kučera ¹; J. Štěpán ml. ²; M. Štelcl ³
Authors‘ workplace: PPCHC Sanus Jihlava, ředitel MUDr. J. Štěpán, CSc. ¹; PPCHC Sanus Hradec Králové, ředitel MUDr. J Štěpán, CSc. ²; Reprogenesis, Brno, vedoucí lékař M. Štelcl ³
Published in: Ceska Gynekol 2018; 83(4): 307-311
Category:

Overview

Objective: To summarize the posibilities of diagnosis of diminished ovarian reserve.

Design: Survey of contemporary knowledge.

Settings: PPCHC, Sanus Jihlava; PPCHC, Sanus Hradec Králové; Reprogenesis, Brno.

Methods: Review of literature.

Conclusion: Voluntary or involuntary motherhood postmonement to the third decade of woman‘s life needs presice evaluation of the ovarian reserve before the infertility treatment. Contemporary there are: 1 hormonal tests (basal and dynamic), 2 ultrasonographic markers of ovarian reserve. The most perspective markers of ovarian reserve seems AMH a AFC.

Keywords: ovarian reserve, reproductive aging, FSH, inhibin B, estradiol, AMH, CCCT, GAST, EFORT, AFC, ovarian volume, ovarian blood flow

Sources

1.   Bansci, LF., Broekmans, FJ., Eijkemans, MJ., et al. Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002, 2, p. 328–336.
2.   Barátová, D., Mekiňová, L., Slabá, K., Crha, I. Operace endometriomů ovaria a ovariální rezerva. Čes Gynek, 2016, 3, s. 182–185.
3.   Broekmans, FJ., Kwee, J., Hendriks, DJ. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Rep Upd, 2006, 6, p. 685–718.
4.   Brodin, T., Bergh, T., Berglund, L., et al. Menstrual cyclelength is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil Steril, 2008, 5, p. 1656–1661.
5.   Cavalho, de BR., Rosa-e-Silva, AC., Rosa-e-Silva, JC., et al. Increased basal FSH levels as predictors of low quality follicles in infertile women with endometriosis. Int J Gyn Obst, 2010, 3, p. 208–212.
6.   Corson, SL., Gutmann, J., Batzer, FR., et.al. Inhibin-B as a test of ovarian reserve for infertile woman. Hum Reprod, 1999, 11, p. 2818–2821.
7.   Durlinger, ALL., Kramer, P., Karels, B., et al. Control of primordial follicle recruitment by anti-müllerian hormone in the mouse ovary. Endocrinology, 1999, 12, p. 5789–5796.
8.   Eldar-Geva, T., Margalioth, EJ., Ben-Cherit, A., et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod, 2002, 9, p. 2331–2337.
9.   Evers, LJ., Slaats, P., Land, JA., et al. Elevated levels of basal 17-beta estradiol predict poor response in patients with normal basal levels of follicle stimulating hormone undergoing in vitro fertilisation. Fertil Steril, 1998, 69, p. 1010–1014.
10.   Faddy, MJ., Gosden, RG., Gougeon, A., et al. Accelerated disappearance of ovarian follicles in mid-life: implication for forecasting menopause. Hum Reprod, 1992, 10, p. 1342–1346.
11.   Fanchin, R., de Ziegler, D., Olivennes, F., et al. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‚poor responders‘ in in vitro fertilization. Hum Reprod, 1994, 9, p. 1607–1611.
12.   Ferin, M., Jewelewitz, R., Warren, M. Menstruační cyklus. Praha: Grada, 1997, s. 15–19.
13.   Hendriks, JD., Kwee, J., Mol, BWJ., et al. Ultrasonography as a tool for the prediction of otcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril, 2007, 4, p. 764–775.
14.   Huser, M., Crha, I., Žáková, J., Ventruba, P. Proces reprodukčního stárnutí ženy – jeho příčiny a možnosti ovlivnění v praxi. Čes Gynek, 2010, 4, s. 353–358.
15.   Järvelä, IY., Sladkevicius, P., Kelly, S., et al. Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. Obstet Gynecol, 6, 2003, p. 816–822.
16.   Kučera, R., Topolčan, O., Rumpíková, T., et al. Stanovení anti-Müllerova hormonu u žen. Čes Gynek, 2013, 3, s. 282–288.
17.   Kwee, J., Elting, ME., Schats, R., et al. Ovarian volume and antral follicle count for the prediction of low and hyperresponders with in vitro fertilization. Reprod Biol Endocrinol, 2007, 5, p. 9.
18.   Kwee, J., Schats, R., McDonnel, J., et al. The clomifen citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for idetification of low responders and hyperresponders to in vitro fertilization. Fertil Steril, 2006, 5, p. 1714–1722.
19.   Lonský, P. Geneticky podmíněné poruchy plodnosti. In Mardešič, T., et al. Diagnostika a léčba poruch plodnosti. Praha: Grada, 2013, s. 53–54.
20.   Luna, ML., Grunfeld, T., Mukherjee, T., et. al. Moderately elevated levels of basal folicle stimulating hormone in young patients predict low ovarian response , but should not be used to disqualify patients from attempting in vitro fertilisation. Fertil Steril, 2007, 4, p. 782–787.
21.   Maheshwari, A., Gibreel, A., Bhattacharya, S., et al. Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy. Reprod Biol Medic Online, 2009, 5, p. 717–734.
22.   Marca, La A., Sighinolfi, G., Radi, D. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reprod Update, 2009, 2, p. 442–509.
23.   Maseelall, PB., Hernandez-Rey, AE., Maagdenberg, T., et al. Antral follicle count is a significant predictor of livebirth in in vitro fertilization cycles. Fertil Steril, 2009, 4, suppl., p. 1595–1597.
24.   Montfrans, van JM., Hoek, A., van Hooff, MH., et. al. Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population. Fertil Steril, 2000, 1, p. 197–103.
25.   Muttukrishna, S., McGarrigle, H., Wakim, R., et al. Antral follicle count, anti-Müllerian hormone and inhibin B: Predictors of ovarian response in assisted reproductive technology. BJOG, 2005, 10, p. 1384–1390.
26.   Nardo, GL., Gelbaya, TA., Wilkinson, H., et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril, 2009, 5, p. 1586–1593.
27.   Navot, D., Rosenwarks, Z., Margalioth, EJ. Prognostic assessment of female fecundity. Lancet, 1987, 2, p. 645–647.
28.   Nelson, SM., Yates, RW., Lyall, H., et al. Anti-Müllerian hormone based aproach to controlled ovarian stimulation for assisted conception. Hum Reprod, 2009, 4, p. 867–875.
29.   Padma, RJ. Ovarian reserve tests. J Hum Reprod Sci, 2011, 4(3), p. 108–113.
30.   Pandilla, SL., Bayati, J., Garcia, JE. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril, 1990, 53, p. 288–294.
31.   Piette, C., de Mouzon, J., Bachelot, A., Spira, A. In vitro fertilization (influence of woman‘s age on pregnancy rates). Hum Reprod, 1990, 5, p. 56–59.
32.   Revelli, A., Marchino, G., Dolfin, E., et al. Live birth after orthotopic grafting of autologous cryopreserved ovarian tissue and spontaneous conception in Italy. Fertil Steril, 2013, 1, p. 227–230.
33.   Rooij, van IJ., Bancsi, LF., Broekmans, FJ., et al. Women older than 40 years of age and those with elevated FSH hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril, 2003, 79, p. 482–488.
34.   Rowe, T. Fertility and a woman‘s age. J Reprod Med, 2006, 3, p. 157–163.
35.   Scott, RT., Hofmann, GE. Prognostic assesment of ovarian reserve. Fertil Steril, 1995, 1, p. 1–11.
36.   Seifer, DB., Lambert-Messerlian, G., Hogan, JW., et. al. Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil Steril, 1997, 1, p. 11–15.
37.   Seifer, DB., Scott, RT. Jr., Bergh, PA., et al. Day 3 serum inhibin B before a rise in day 3 folicle stimulating hormone. Fertil Steril, 1999, 72, p. 63–65.
38.   Sharif, K., Elgendy, M., Lashen, H., Afnan, M. Age and basal folicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol, 1998, 1, p. 107–112.
39.   Sirsikar, M., Pinnelli, VBK., Shrabani, M., Jayashankar, CA. Anti-Müllerian hormone in health and disease: a review. Int J Res Med Sci, 2016, 4, p. 2514–2520.
40.   Tinkanen, H., Bläuer, M., Laippala, P., et. al. Correlation between serum inhibin B and other indicators of the ovarian function. Eur J Obstet Gynek Reprod Biol, 2001, 1, p. 109–113.
41.   Verhagen, TEM., Hendriks, DJ., Bansci, LFJMM., et al. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Up, 2008, 2, p. 99–100.
42.   Visser, JA., Themen, AP. Anti-Müllerian hormone and folliculogenesis. Mol Cell Endocrin, 2005, 1–2, p. 81–86.
43.   Vrublovský, P. Hodnota AMH jako prediktor výsledku ovariální stimulace. Čes Gynek, 2016, 1, s. 23–26.
44.   Watt, HA., Legedza, AT., Ginsburg, ES., et al. The prognostic value of age and follicle-stimulating hormone in women over forty years of age undergoing in vitro fertilisation. Assist Reprod Gennet, 2000, 5, p. 264–268.
45.   Weenen, C., Laven, JS., von Bergh, AR., et al. Anti-Müllerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod, 2004, 2, p. 77–83.
46.   Wood, JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol, 1989, 11, p. 61–109.
47.   Žáčková, T., Mardešič, T., Kučera, T. Úspěšnost mimotělního oplodnění a demografické aspekty neplodnosti v ČR. Sanquis, 2005, 39, s. 34